47 / 136
AfroCentric INTEGRATED ANNUAL REPORT 2016
45
Stakeholder group Overview
Impact and engagement
Expectations/concerns
How we respond
Material
regulators
The Johannesburg Stock
Exchange
The JSE offers secure,
efficient primary and
secondary capital markets
across a diverse range of
securities, supported by its
post-trade and regulatory
services
The JSE is the presiding authority
over AfroCentric’s public listing.
It creates a healthy exchange
for trade and engagement and
the relationship is managed by
Group Finance with the Groups
corporate sponsors, Sasfin
Securities
Adherence to JSE Listings
requirements
IFRS compliance
Corporate
governance report,
page 81
Group Annual
Financial Statements
(supplementary
information)
Competition Commission
The stated purpose of the
Competition Act, 1998 (Act
No 89 of 1998) is to promote
and maintain competition in
South Africa
The Competition Commission
ensures that AfroCentric does
not act anti-competitively, and
more broadly controls restrictive
practices and ensures fair
competition in the industry.
Engagement takes place via
Group Compliance as required
Compliance
Unfair competitive
advantage
CEO’s report,
page 26
Conducting business
in an ethical manner
Providers of
Information
Technology
Helios
provides network
connectivity and outsourced
technology solutions
Allegra
provides a platform
for all clinical information
management and
pharmaceutical care through
a software solutions
Allegra also has a synergistic
relationship with Helios.
Allegra provides technology
solutions that impact and
are relied upon by Group
companies and clients alike.
Therefore, Allegra’s external
interface impacts on the
Group’s value creation and
reputation
Efficient and reliable operational
functionality of IT systems is a
critical enabler in a business
powered by technology. The
relationship with Helios is a key
dependency as Medscheme is
Helios’s key client
Allegra provides the platform for
healthcare networks to supply
their services and share data
with the funders like Polmed.
The result is better patient care
through co-ordination and data
sharing. The platform enables
every step, from patient booking,
to visit data collection, claiming
and sharing of consented data
with the funder in real time
The extensive pharmacy clinic
network footprint enables the
group to deliver new innovative
wellness and disease risk
management solution quickly
in collaboration with the
providers. This model is now
being expanded to pharmacy
dispensing and other healthcare
networks like biokineticists,
Independent nurses and primary
care practitioners. This will
enable Medscheme and other
companies in the group to deliver
an enhanced member experience
and help manage the funders risk
Contracting
Service level agreements
and client service delivery
Client service
Business
partners
Medscheme
Medscheme provides a
full spectrum of health
administration and health
risk management services
Helios
Helios specialises in
delivering innovative
technology solutions and
creating efficiencies for
clients in the health industry
Medscheme is the largest
revenue generator in the Group.
Its systems and processes need to
be operational at all times making
the relationship with Helios of
vital importance. Due to its size,
Medscheme’s efficiencies impact
other companies in the Group,
and it in turn is impacted by their
sound financial management
Engagement with Medscheme
takes place continuously
Grow client base
including public sector
involvement
Upgrading to an
enhanced IT platform
called Fusion
Growth
Diversifying revenue
sources
Cost consciousness
Client service